GTG 2.63% 7.4¢ genetic technologies limited

3 doctors agreed that BREVAGENplus is the leading breast cancer...

  1. 336 Posts.
    lightbulb Created with Sketch. 8
    3 doctors agreed that BREVAGENplus is the leading breast cancer clinical test available, and also commented on its accuracy.
 
watchlist Created with Sketch. Add GTG (ASX) to my watchlist
(20min delay)
Last
7.4¢
Change
-0.002(2.63%)
Mkt cap ! $9.784M
Open High Low Value Volume
7.6¢ 7.7¢ 7.4¢ $631 8.312K

Buyers (Bids)

No. Vol. Price($)
1 8352 7.4¢
 

Sellers (Offers)

Price($) Vol. No.
7.7¢ 5744 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
GTG (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.